Researchers find potential solution to melanoma's resistance to vemurafenib
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
Cancer
Feb 28, 2012 |
not rated yet |
0
|
Combination therapy may enhance gemcitabine activity
Oncologists who treat patients with pancreatic cancer may be one step closer to understanding why gemcitabine, the only currently available treatment, works in some cases but not in others, according to a paper in Cancer Di ...
Cancer
Feb 28, 2012 |
3 / 5 (2) |
0
Calls for policy changes as lives put at risk by bureaucracy
A European Parliament event to discuss how EU legislation has negatively affected the treatment received by children and adolescents has marked International Childhood Cancer Day - 15th February.
Cancer
Feb 15, 2012 |
not rated yet |
0
New tumor suppressor gene identified
A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for th ...
Cancer
Feb 13, 2012 |
4.8 / 5 (4) |
0
First prospective clinical trial of adaptive radiotherapy for head and neck cancer patients
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy ...
Cancer
Feb 09, 2012 |
5 / 5 (1) |
0
Soy isoflavone supplements did not provide breast cancer protections
Soy isoflavone supplements did not decrease breast cancer cell proliferation in a randomized clinical trial, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Resear ...
Cancer
Feb 03, 2012 |
not rated yet |
0
|
Study examines drug resistance in ALK positive lung cancer
Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell ...
Cancer
Jan 19, 2012 |
not rated yet |
0
Researchers find new, noninvasive way to identify lymph node metastasis
Using two cell surface markers found to be highly expressed in breast cancer lymph node metastases, researchers at Moffitt Cancer Center, working with colleagues at other institutions, have developed targeted, fluorescent ...
Cancer
Jan 12, 2012 |
not rated yet |
0
American Society of Clinical Oncology issues annual report on progress against cancer
The American Society of Clinical Oncology (ASCO) today released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest ...
Cancer
Dec 05, 2011 |
not rated yet |
0
'Seena' clinical trials named for pancreatic cancer advocate
A son's passion to find a cure for the cancer that claimed the life of his mother has led to a new series of clinical trials under a Translational Genomics Research Institute (TGen) initiative to find a cure for pancreatic ...
Cancer
Dec 01, 2011 |
not rated yet |
0
Drug may slow spread of deadly eye cancer
A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to researchers at Washington University School of Medicine in St. ...
Cancer
Nov 28, 2011 |
not rated yet |
0
|
Arginine restores T-cell ability to target cancer
In many cases, tumors suppress a patient's immune system in a way that keeps the cancer safe from immune system attack. This is particularly true for patients with glioblastoma, a primary brain tumor that carries a prognosis ...
Cancer
Nov 22, 2011 |
5 / 5 (1) |
0
Signaling pathway linked to inflammatory breast cancer may drive disease metastasis
Amplification of anaplastic lymphoma kinase, which has been reported in other cancers such as non-small cell lung cancers, may be a primary driver of the rapid metastasis that patients with inflammatory breast cancer experience.
Inflammatory disorders
Nov 13, 2011 |
not rated yet |
0
Vaccine for metastatic breast, ovarian cancer shows promise
Treatment with a recombinant poxviral vaccine showed a positive response in both metastatic breast cancer and ovarian cancer, according to a trial published in Clinical Cancer Research, a journal of the American Association for Ca ...
Cancer
Nov 08, 2011 |
not rated yet |
0
|
Radiation plus hormone therapy greatly improves survival
Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at ...
Cancer
Nov 03, 2011 |
not rated yet |
0
